Lipoglycopeptide Antibacterial [EPC] - N0000191281

Pharmacologic Class Information

Pharmacologic Code N0000191281
Pharmacologic Name Lipoglycopeptide Antibacterial
Pharmacologic Uses
  • lipoglycopeptide antibacterial
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Lipoglycopeptide Antibacterial

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Lipoglycopeptide Antibacterial [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
57970-100Dalvance Non-Proprietary Name: DalbavancinInjection, Powder, For SolutionIntravenousAllergan, Inc.ACTIVE
66220-315Vibativ Non-Proprietary Name: Telavancin HydrochlorideInjection, Powder, Lyophilized, For SolutionIntravenousCumberland Pharmaceuticals Inc.ACTIVE
70842-140Orbactiv Non-Proprietary Name: OritavancinInjection, Powder, Lyophilized, For SolutionIntravenousMelinta Therapeutics, LlcACTIVE
70842-225Kimyrsa Non-Proprietary Name: Oritavancin DiphosphateInjection, Powder, Lyophilized, For SolutionIntravenousMelinta Therapeutics, LlcACTIVE